Technical Analysis for KPTI - Karyopharm Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 17.04 -9.51% -1.79
KPTI closed down 9.51 percent on Friday, January 17, 2020, on 2.07 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical KPTI trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Crossed Above 20 DMA Bullish -9.51%
Bollinger Band Squeeze Range Contraction -9.51%
Up 3 Days in a Row Strength -9.51%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company's lead drug candidate includes Selinexor, an oral selective inhibitors of nuclear export (SINE) compound that specifically blocks XPO1 cargo binding is in Phase I clinical trials in patients with heavily pretreated relapsed and/or refractory hematological and solid tumor malignancies. Its other drug candidates comprise KPT-350 and related SINE compounds; PAK4 inhibitors; and Verdinexor, a SINE compound that is in Phase IIb clinical trials in pet dogs with newly-diagnosed or first relapse after chemotherapy lymphomas. The company was founded in 2008 and is based in Natick, Massachusetts.
Medicine Cancer Pharmaceutical Diseases Treatment Of Cancer Oncology Chemotherapy Occupational Safety And Health Antibody Drug Conjugates Pixantrone

Is KPTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.09
52 Week Low 3.92
Average Volume 1,207,334
200-Day Moving Average 10.22
50-Day Moving Average 17.21
20-Day Moving Average 18.61
10-Day Moving Average 18.25
Average True Range 1.04
ADX 23.73
+DI 22.91
-DI 28.37
Chandelier Exit (Long, 3 ATRs ) 16.96
Chandelier Exit (Short, 3 ATRs ) 19.83
Upper Bollinger Band 19.94
Lower Bollinger Band 17.27
Percent B (%b) -0.09
BandWidth 14.35
MACD Line 0.25
MACD Signal Line 0.49
MACD Histogram -0.2467
Fundamentals Value
Market Cap 803.23 Million
Num Shares 47.1 Million
EPS -2.69
Price-to-Earnings (P/E) Ratio -6.33
Price-to-Sales 2836.82
Price-to-Book 2.82
PEG Ratio -0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.91
Resistance 3 (R3) 20.20 19.55 19.43
Resistance 2 (R2) 19.55 18.82 19.40 19.27
Resistance 1 (R1) 18.29 18.37 17.97 18.00 19.11
Pivot Point 17.64 17.64 17.47 17.49 17.64
Support 1 (S1) 16.38 16.91 16.06 16.09 14.97
Support 2 (S2) 15.73 16.46 15.58 14.81
Support 3 (S3) 14.47 15.73 14.65
Support 4 (S4) 14.18